Definitive Contract HHSN268200900044C
Award Date 8/26/09
Potential Completion Date 2/28/10
Potential Value $159K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92109, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to Vala Sciences Inc. The $880,128 definitive cost-plus-fixed-fee contract is for the development of cell-based bioassays using induced pluripotent stem (iPS) cell lines. The goal is to provide research and development services related to assays and imaging systems for pharmaceutical testing. Vala Sciences has...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $299,923 Small Business Innovation Research (SBIR) Phase I contract to Vala Sciences Inc., a for-profit organization, to develop a microscopic imaging-based assay to identify novel therapeutics for breast cancer. The contract is designated as a total small business set aside. Through past federal grant awards, Vala Sciences has developed screening platforms and assays utilizing human...
- This is a $223,048 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Vala Sciences Inc., a small business, to develop an in vitro assay to study the initiation of breast cancer metastasis. The contract is a firm fixed-price definitive contract. Vala Sciences has previously received SBIR and project grant awards from the National Institutes of Health (NIH) to develop screening platforms and assays for pharmaceutical testing using...
- This is a $1,937,903 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI) to Vala Sciences Inc. on September 24, 2010. The contract is for research and development related to other sciences, with a period of performance ending on April 30, 2014. Vala Sciences is a for-profit company that provides products and services to help drug developers and researchers understand how human cells respond to drug compounds, including through the use of human induced...
- This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Accel Diagnostics, LLC, a for-profit limited liability company based in Houston, TX. The contract is valued at $212,552.00 and is focused on developing a minimally invasive test for detecting chemotherapy-induced cardiotoxicity. The contract has a period of performance from August 10, 2016 to August 9, 2017 and is a Firm Fixed Price (FFP)...
- This federal contract award, valued at $21,119.70, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to Government Scientific Source Inc., a for-profit organization that specializes in providing laboratory products and equipment to federal agencies. The purpose of this contract is to supply reagents for sequencing to support ongoing clinical research at NHLBI to understand rare and...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a "Multiplex Label-Free Nanowell Technology...